Some 1-[(Benzofuran-2-yl)methyl]imidazoles as inhibitors of 17α-hydroxylase:17, 20-lyase (P450 17) and their specificity patterns

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 10, 1998, Pages 1109-1116

  Bahshwan, Saleh A ^a   Owen, Caroline P ^a   Nicholls, Paul J ^a   Smith, H John ^a   Ahmadi, Masoud ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 [(BENZOFURAN 2 YL)METHYL]IMIDAZOLE; ALDOSTERONE; ENZYME INHIBITOR; HYDROCORTISONE; IMIDAZOLE DERIVATIVE; KETOCONAZOLE; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE; UNCLASSIFIED DRUG;

ADRENAL GLAND; ARTICLE; CATTLE; CONTROLLED STUDY; DRUG POTENCY; ENZYME SPECIFICITY; HORMONE SYNTHESIS; HUMAN; NONHUMAN; PROSTATE CANCER; STEROIDOGENESIS; TESTIS;

EID: 0031770240     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb03320.x     Document Type: Article

References (34)

1. Al-Hamrouni, A., Ahmadi, M., Nicholls, P. J., Smith, H. J., Lombardi, P., Pestellini, V. (1997) 1-[(Benzofuran-2-yl)phenylmethyl]imidazoles as inhibitors of 17α-hydroxylase: 17,20-lyase (P450 17): species and tissue differences. Pharm. Sci. 3: 259-263
2. Anderson, K. M., Liao, S. (1968) Selective retention of dihydrotestosterone by prostatic nuclei. Nature 219: 277-279
3. Andersson, S. (1995) 17β-Hydroxysteroid dehydrogenase: isozymes and mutations. J. Endocrinol. 146: 197-200
4. Ayub, M., Levell, M. J. (1989) Inhibition of human adrenal steroidogenic enzymes in vitro by imidazole drugs including ketoconazole. J. Steroid Biochem. 32: 515-524
5. Bahshwan, S. A. (1997) Pharmacological and Biochemical Studies of Novel Potential Anticancer Agents of Relevance to Clinical Pharmacy. Ph. D. Thesis, University of Wales
6. Barrie, S. E., Rowlands, M. G., Foster, A. B., Jarman, M. (1989) Inhibition of 17α-hydroxylase/C17-C20 lyase by bifluranol and its analogues. J. Steroid Biochem. 33: 1191-1195
7. Barrie, S. E., Potter, G. A., Haynes, B. P., Jarman, M. (1995) CB7598: a potent inhibitor of steroidal 17α-hydroxylase/c17,20 lyase. A potential new drug for the treatment of prostatic cancer. J. Pharm. Pharmacol. 47: 1076
8. Bhatnager, A. S., Haeusler, A., Schieweck, K., Lang, M., Bowman, R. (1990) Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. J. Steroid Biochem. Mol. Biol. 37: 1021-1027
9. Biswas, M. G., Russell, D. W. (1997) Expression cloning and characterization of oxidative 17β and 3α-hydroxysteroid dehydrogenases from rat and human prostate. J. Biol. Chem. 272: 15959-15966
10. Chiarodo, A. (1991) National Cancer Institute round table on prostate cancer: future research directions. Cancer Res. 51: 2498-2505
11. Crawford, E. D., Blumenstein, B. A., Goodman, P. J. (1990) Leuprolide with and without flutamide in advanced prostatic cancer. Cancer 66: 1039-1044
12. De Coster, R., Caers, I., Coene, M.-C., Amery, W., Beerens, D., Haelterman, C. (1986) Effects of high-dose ketoconazole therapy on the main plasma testicular and adrenal steroids in previously untreated prostatic cancer patients. Clin. Endocrinol. 24: 657-664
13. De Coster, R., Coene, M. C., Van Camp, C., Van Camp, K., Beerens, D., Cools, W. (1989) Comparative effects of ketoconazole on rat, dog and human testicular steroidogenesis. J. Enzyme Inhib. 2: 261-268
14. De Coster, R., Wouters, W., Brynseels, J. (1996) P450-dependent enzymes as targets for prostate cancer therapy. J Steroid Biochem. Mol. Biol. 56: 133-143
15. Denis, L. J. (1991) Controversies in the management of localized and metastatic prostatic cancer. Eur. J. Cancer. 27: 333-341
16. Gibson, G., Skett, P. (1994) Introduction to Drug Metabolism. Chapman and Hall, London, p. 266
17. Higashi, Y., Omura, M., Suzuki, K., Inano, H., Oshima, H. (1987) Ketoconazole as a possible universal inhibitor of cytochrome P450 dependent enzymes: its mode of inhibition. Endocrinology 34: 105-115
18. Klus, G. T., Nakamura, J., Li, J.-S., Ling, Y.-Z., Son, C., Kemppainen, J. A., Wilson, E. M., Brodie, A. M. H. (1996) Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis. Cancer Res. 56: 4956-4964
19. Knuth, U. A., Hano, R., Nieschlag, E. (1984) Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men. J. Clin. Endocrinol. Metab. 59: 963-969
20. Lake-Bakaar, G., Scheuer, P. J., Sherlock, S. (1987) Hepatic reactions associated with ketoconazole in the United Kingdom. Br. Med. J. 294: 419-422
21. Li, J., Li, Y., Son, C., Banks, P., Brodie, A. (1992) 4-Pregnene-3-one-20β-carboxaldehyde, a potent inhibitor of 17α-hydroxylase/C17,20-lyase of 5α-reductase. J. Steroid Biochem. Mol. Biol. 42: 313-320
22. Martel, C., Rheaume, E., Takanashi, M., Trudel, C., Couet, J., Luu-The, V., Simard, J., Labrie, F. (1992) Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J. Steroid Biochem. Mol. Biol. 41: 597-603
23. McCague, R., Rowlands, M. G., Barrie, S. E., Houghton, J. (1990) Inhibition of enzymes of estrogen and androgen biosynthesis by esters of 4-pyridylacetic acid. J. Med. Chem. 33: 3050-3055
24. Oritz de Montellano, P. R. (1986) Cytochrome P450. Plenum Press, New York, p. 273
25. Owen, C. P. (1995) Synthesis and Evaluation of Inhibitors of 17α-Hydroxylase-17,20-lyase and Aromatase as Potential Anti-tumour Agents. Ph.D. Thesis, University of Wales
26. Pepper, C., Smith, H. J., Barrell, K. J., Nicholls, P. J., Hewlins, M. J. (1994) Racemization of drug enantiomers by benzylic proton abstraction at physiological pH. Chirality 6: 400-404
27. 17,20-lyase): potential agents for the treatment of prostatic cancer. J. Med. Chem. 38: 2463-2471
28. Presti, J. C., Fair, W. R., Andriole, G., Sogani, P. C., Seidman, E. J., Ferguson, D., Ng, J., Gormley, G. J. (1992) Multicenter, randomised, double blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer. J. Urol. 148: 1201-1204
29. Shaw, M. A., Nicholls, P. J., Smith, H. J. (1988) Amino-glutethimide and ketoconazole: historical perspectives and future prospects. J. Steroid Biochem. 31: 137-146
30. Sonino, N. (1987) The use of ketoconazole as an inhibitor of steroid production. New Engl. J. Med. 317: 812-818
31. Trachtenberg, J., Toledo, A. (1991) Evidence for action in hormone refractory disease. R75251, a novel non-toxic treatment of hormone refractory prostatic cancer. J. Urol. 145: A420
32. Trachtenberg, J., Pont, A. (1984) Ketoconazole therapy for advanced prostatic cancer. Lancet II: 433-435
33. Vanden Bossche, H., Willemsens, G. (1991) Retinoic acid and cytochrome P450. In: Saurat, J.-H. (ed.) Retinoids: 10 Years On. Karger, Basle, pp 79-88
34. arom and P450 17. J. Med. Chem. 39: 834-841